Emtricitabine (FTC)
Emtricitabine (FTC) (S1704-GRP)
Products
Description
Emtricitabine (FTC) is a new nucleoside agent that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus. It is a reverse transcriptase inhibitor. Intracellular half-life is 39 h.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | S1704 |
| Target | Reverse Transcriptase |